Eric Hsu is a corporate and securities partner in the life sciences practice at Wilson Sonsini Goodrich & Rosati. He represents emerging growth companies in areas such as medical devices, digital health, and biotechnology. Eric advises public and private companies on general corporate matters, mergers and acquisitions, initial public offerings, public company reporting, strategic partnerships, venture capital financings, and private equity and debt financings.

Alex focuses on representing clients in the biotechnology, pharmaceutical, medical device, diagnostic, and digital health industries.

Myra is a partner in the firm’s tax practice and represents clients in connection with federal income tax planning for a variety of corporate transactions in domestic and cross-border settings.

Amanda Urquiza is a partner at Wilson Sonsini Goodrich & Rosati, where she practices corporate and securities law. Amanda has extensive experience advising public companies and their boards. Her practice includes all aspects of company representation, including corporate governance, SEC compliance, 1934 Act issues, public offerings, private placements, and mergers and acquisitions. She brings a nuanced perspective to her practice, driven by her broad range of experience, including time spent in-house and practicing internationally.

Dr. Rex Watkins is an associate at Wilson Sonsini Goodrich & Rosati, where his practice focuses on patent procurement—both domestic and international—for life sciences, physical science, medical device, and mechanical apparatus clients. In addition to patent drafting and prosecution, Rex has experience with freedom-to-operate analyses, validity and infringement opinions, IP due diligence, patent litigation, and licensing.